| Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration F Gonzalez-Ortiz, M Turton, PR Kac, D Smirnov, E Premi, R Ghidoni, ... Brain 146 (3), 1152-1165, 2023 | 137 | 2023 |
| Plasma and CSF biomarkers in a memory clinic: head‐to‐head comparison of phosphorylated tau immunoassays NJ Ashton, A Puig‐Pijoan, M Milà‐Alomà, A Fernández‐Lebrero, ... Alzheimer's & Dementia 19 (5), 1913-1924, 2023 | 119 | 2023 |
| Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications F Gonzalez-Ortiz, PR Kac, WS Brum, H Zetterberg, K Blennow, TK Karikari Molecular neurodegeneration 18 (1), 18, 2023 | 103 | 2023 |
| Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease PR Kac, F Gonzalez-Ortiz, J Simrén, N Dewit, E Vanmechelen, ... Alzheimer's Research & Therapy 14 (1), 65, 2022 | 41 | 2022 |
| Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid M Bilgel, Y An, KA Walker, AR Moghekar, NJ Ashton, PR Kac, TK Karikari, ... Alzheimer's & Dementia 19 (10), 4335-4345, 2023 | 33 | 2023 |
| Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease Y Yakoub, NJ Ashton, C Strikwerda‐Brown, L Montoliu‐Gaya, TK Karikari, ... Alzheimer's & Dementia 19 (12), 5620-5631, 2023 | 31 | 2023 |
| A novel ultrasensitive assay for plasma p‐tau217: performance in individuals with subjective cognitive decline and early Alzheimer's disease F Gonzalez‐Ortiz, PCL Ferreira, A González‐Escalante, L Montoliu‐Gaya, ... Alzheimer's & Dementia 20 (2), 1239-1249, 2024 | 28 | 2024 |
| Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study L Montoliu-Gaya, D Alcolea, NJ Ashton, J Pegueroles, J Levin, B Bosch, ... EBioMedicine 90, 2023 | 25 | 2023 |
| Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology PR Kac, F González-Ortiz, A Emeršič, M Dulewicz, S Koutarapu, M Turton, ... Nature communications 15 (1), 2615, 2024 | 18 | 2024 |
| Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease F Gonzalez-Ortiz, BE Kirsebom, J Contador, JE Tanley, P Selnes, ... Nature Communications 15 (1), 2908, 2024 | 13 | 2024 |
| Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance development J Mlost, P Kac, M Kędziora, K Starowicz Neuropharmacology 204, 108908, 2022 | 13 | 2022 |
| Association of serum brain-derived tau with clinical outcome and longitudinal change in patients with severe traumatic brain injury F Gonzalez-Ortiz, M Dulewicz, NJ Ashton, PR Kac, H Zetterberg, ... JAMA Network Open 6 (7), e2321554-e2321554, 2023 | 12 | 2023 |
| Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias F Gonzalez‐Ortiz, TK Karikari, GM Bentivenga, S Baiardi, A Mammana, ... Alzheimer's & Dementia 20 (1), 745-751, 2024 | 8 | 2024 |
| Longitudinal progression of blood biomarkers reveals a key role of astrocyte reactivity in preclinical Alzheimer’s disease VR Varma, Y An, PR Kac, M Bilgel, A Moghekar, T Loeffler, D Amschl, ... medRxiv, 2024 | 7 | 2024 |
| Preanalytical stability of plasma/serum brain‐derived tau F Gonzalez‐Ortiz, A Dias, M Turton, R Magalhães, PR Kac, M Correia, ... Alzheimer's & Dementia 19 (10), 4764-4770, 2023 | 4 | 2023 |
| The Alzheimer’s Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study NJ Ashton, A Keshavan, WS Brum, U Andreasson, B Arslan, M Droescher, ... medRxiv, 2024 | 2 | 2024 |
| Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression MR Duggan, GT Gomez, CM Joynes, M Bilgel, J Chen, N Fattorelli, ... Brain, Behavior, and Immunity 120, 604-619, 2024 | 2 | 2024 |
| Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates T Islam, H Kvartsberg, A Sehrawat, PR Kac, B Becker, M Olsson, ... Alzheimer's & Dementia 20 (4), 2894-2905, 2024 | 2 | 2024 |
| Longitudinal Blood Biomarker Trajectories in Preclinical Alzheimer’s Disease Y Yakoub, NJ Ashton, TK Karikari, C Strikwerda‐Brown, L Montoliu‐Gaya, ... Alzheimer's & Dementia 18, e064811, 2022 | 2 | 2022 |
| Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis A Emeršič, TK Karikari, PR Kac, F Gonzalez-Ortiz, M Dulewicz, NJ Ashton, ... Multiple Sclerosis and Related Disorders 90, 105801, 2024 | 1 | 2024 |
